Read my take on whether COVID-19 antivirals might prove to be efficacious in the prevention and/or treatment of long COVID. It’s an intriguing idea, but the answer remains to be seen.
Lisez mon point de vue pour savoir si les antiviraux contre la COVID-19 pourraient s’avérer efficaces dans la prévention et/ou le traitement de la COVID-19 de longue durée. C’est une idée intrigante, mais la réponse reste à voir.
Dr. Cristina Mussini erörtert, ob sich antivirale COVID-19-Medikamente bei der Prophylaxe und/oder Behandlung von Long COVID als nützlich erweisen, von Clinical Care Options (CCO)
Ecco la mia opinione sulla possibilità che gli antivirali contro la COVID-19 si rivelino efficaci nella prevenzione e/o nel trattamento della Long COVID. È un'idea intrigante, ma la risposta è ancora da verificare.
Lea mi opinión sobre si los antivirales contra la COVID-19 podrían resultar eficaces en la prevención y/o el tratamiento de la COVID persistente. Es una idea intrigante, sin embargo la respuesta está por ver.
In this video module, learn the importance of early antiviral therapy for high-risk patients to prevent severe disease and potentially long-term sequelae. Review evolving data regarding long COVID, including the epidemiology, common symptoms, and possible prevention and management strategies.
Listen to expert insights from Jens D. Lundgren, MD, DMSc, and Barbara Rath, MD, PhD, HDR, on key treatment updates for outpatient COVID-19 and what we currently know about diagnosing and managing long COVID.
Read European expert faculty summaries of the outpatient management of acute COVID-19 and long COVID.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.